Solriamfetol: all 29 studies that test it
Page 1 of 1. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.
- An Open-Label Study to Assess the Long-Term Safety of Solriamfetol in Children and Adolescents With ADHDEnrolling by invitationNCT07773883Phase 3
- Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using SolriamfetolRecruitingNCT07484217Phase 3
- A Study to Assess the Long-term Safety and Efficacy of Solriamfetol in Subjects With Binge Eating DisorderEnrolling by invitationNCT06878976Phase 3
- Efficacy and Tolerance of Solriamfetol in Patients Affected with Idiopathic Hypersomnia.Not yet recruitingNCT06590662Phase 2
- Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)RecruitingNCT06568367Phase 3
- Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using SolriamfetolRecruitingNCT06413433Phase 3
- Solriamfetol for the Treatment of Multiple Sclerosis FatigueRecruitingNCT06170970Phase 2
- A Controlled Study of Solriamfetol for Attention Deficit Hyperactivity Disorder (ADHD) in AdultsCompletedNCT04839562Phase 2/3Results posted
- Solriamfetol's Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-controlled StudyCompletedNCT04789174Phase 4Results posted
- Clinical Trial of Solriamfetol for Excessive Sleepiness Related to Shift Work DisorderTerminatedNCT04788953Phase 4Results posted
- A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive SleepinessCompletedNCT03037203Phase 2Results posted
- Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in NarcolepsyCompletedNCT02806908Phase 2Results posted
- Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in OSACompletedNCT02806895Phase 2Results posted
- "A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA"CompletedNCT02348632Phase 3Results posted
- "Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"CompletedNCT02348619Phase 3Results posted
- "Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"CompletedNCT02348606Phase 3Results posted
- "Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcolepsy"CompletedNCT02348593Phase 3Results posted
- A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With NarcolepsyCompletedNCT01681121Phase 2Results posted
- A Study of the Safety and Effectiveness of ADX-N05 in the Treatment of Excessive Daytime SleepinessCompletedNCT01485770Phase 2Results posted
- RECOVER-SLEEP: Platform Protocol, Appendix_A (Hypersomnia)CompletedNCT06404099Phase 2
- RECOVER-SLEEP: Platform ProtocolCompletedNCT06404086Phase 2
- Progressing TAAR-1, Dopamine, and Norepinephrine in Depression Using SolriamfetolCompletedNCT06360419Phase 3
- A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Solriamfetol in the Treatment of Excessive Daytime Sleepiness (EDS) in Patients with Obstructive Sleep Apnea (OSA)CompletedNCT06103825Phase 3
- A Study to Assess the Efficacy and Safety of Solriamfetol in Subjects With ADHD (FOCUS)CompletedNCT05972044Phase 3
- Solriamfetol and CBT-I in Patients With Insomnia DisorderCompletedNCT05838430Phase 4
- Evaluate Sunosi® PK in Breast Milk and Plasma of Healthy Postpartum Women Following Single Dose Oral AdministrationCompletedNCT05008341Phase 1
- A Trial of Solriamfetol in the Treatment of Myalgic Encephalomyelitis/Chronic Fatigue SyndromeCompletedNCT04622293Phase 4
- Solriamfetol in Binge Eating DisorderStatus unknownNCT04602936Phase 4
- A 6 Week Study to Determine the Effectiveness of R228060 in Adult Subjects With Major Depressive DisorderCompletedNCT00073203Phase 2